Evan Feinberg Ph.D.

Evan is the CEO and co-founder of Genesis. Evan founded Genesis in 2019 to further develop and apply AI and simulation research he conducted in Vijay Pande’s lab at Stanford University. This research included a groundbreaking physics-based ML framework called PotentialNet, which Evan developed to work for challenging and data-poor drug targets. Evan earned his B.S. in applied physics from Yale University and his Ph.D. in computational biophysics from Stanford University. His work has appeared in journals including Science, Nature, ACS Central Science, and the Journal of Medicinal Chemistry. He has been recognized as an honoree in the Forbes 30 Under 30 list for his work, and he has earned recognition for Genesis in the Forbes AI 50 for several consecutive years.